Chin Bin Eap

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


416 publications

... | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | ...
2008
 
Genotyping to optimize antipsychotic drug treatment
Eap Chin, 2008. p. 86 dans International Journal of Neuropsychopharmacology, International Journal of Neuropsychopharmacology. Peer-reviewed.
[DOI][serval:BIB_72414C8617CE]
 
Impact of oral Cannabis on driving skills and genetic vulnerability to psychotic symptoms
Giroud C., Eap C.B., Favrat B., Sporkert F., Augsburger M., Rochat B., Montoya J.P., Castella V., Mangin P., 2008., Beiträge zum XV. Symposium der Gesellschaft für Toxigologische und Forensische Chemie. - Mosbach, 18-21. April 2007 pp. 193-203 dans Pragst F., Aderjan R. (eds.) Aktuelle Beiträge zur Forensischen und Klinischen Toxikologie. Fahreignung, K.O.-Mittel, Toxikokinetik, Analytische Methoden, Symposium der Gesellschaft für Toxicologische und Forensische Chemie : XV, Gesellschaft für Toxigologische und Forensische Chemie.
[serval:BIB_FE71E278D1D4]
 
Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Fontana Massimiliano, Aubert John-David, Ansermot Nicolas, Fathi Marc, Pascual Manuel, Eap Chin-Bin, 2008. Pharmacogenetics and Genomics, 18 (4) pp. 307-315. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B47AB7C75055]
 
La génétique de l'hypertension: rôle des gènes CYP3A5 et ABCB1 dans le contrôle de la tension artérielle
Bochud Murielle, Eap Chin B., Bovet Pascal, Burnier Michel, 2008. Kardiovaskuläre Medizin, 11 (11) pp. 353-360.
[serval:BIB_178322875288]
 
Metabolic syndrome and atypical antipsychotics: Recommendations and clinical management,Syndrome métabolique et antipsychotiques atypiques: Recommandations et prise en charge clinique
Choong Eva, Conus Philippe, Eap Chin, 2008. revue médicale suisse, 4 (171) pp. 1994-6.
[DOI][serval:BIB_A537F0B03C03]
 
Mico-cocktail validation for CYP3A and CYP2D6 assessment using a low dose of midazolam (0.075 mg) and dextromethorphan (2.5 mg)
Daali Y., Samer C., Eap C., Rebsamen M., Rossier M., Dayer P., Desmeules J., 2008. pp. 80S dans 76e Assemblée annuelle de la Société Suisse de Médecine Interne, Médecine et Société, Medizin und Gesellschaft, Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
[serval:BIB_BE34F6BB97FB]
Monographs on drugs which are frequently analyzed in therapeutic drug monitoring = Arzneimittel-Monographien für Medikamente, die regelmässig im Rahmen des Therapeutic Drug Monitorings analysiert werden
Rentsch K., Eap C.B., Fathi M., Grignaschi N., Magnin J.L., Thormann W., Todesco L., Werner D., 2008. LaboratoriumsMedizin = Journal of Laboratory Medicine, 32 (5) pp. 372-381. Peer-reviewed.
[URN][DOI][WoS][serval:BIB_B183FFF0DEF4]
 
No influence of ABCB1 haplotypes on methadone dosage requirement
Crettol Séverine, Déglon Jean-Jacques, Besson Jacques, Croquette-Krokar Marina, Hämmig Robert, Gothuey Isabelle, Monnat Martine, Eap Chin-Bin, 2008. Clinical Pharmacology and Therapeutics, 83 (5) pp. 668-669. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5CEBA2B2D973]
 
Over- and underreporting of recent drug use in subjects entering an inpatient detoxification unit
Zullino Daniele Fabio, Krenz Sonia, Eap Chin-Bin, Benguettat Djamel, Khan R., 2008. European Journal of Medical Research, 13 (1) pp. 15-20. Peer-reviewed.
[WoS][Pmid][serval:BIB_A385C95B7296]
 
Pharmacogenetics of clozapine: in vivo role of cytochrome P450 isoforms and P-Glycoprotein
Jaquenoud Sirot Eveline, Knezevic B., Perla Morena Gina, Baumann Pierre, Eap Chin Bin, 2008. dans Pharmacopsychiatry, Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_7BD695DD2CB3]
 
Response to "methadone-induced QTc prolongation: is it due to stereoselective block of hERG or to inappropriate QT interval correction?"
Crettol Séverine, Schlaepfer Jürg, Abriel Hugues, Eap Chin-Bin, 2008. Clinical Pharmacology and Therapeutics, 83 (5) p. 672. Peer-reviewed.
[DOI][WoS][serval:BIB_318CB91606C3]
 
Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizer: evidence of a safer cardiac profile of (R)-methadone
Eap Chin Bin, Crettol Séverine, Rougier Jean-Sébastien, Schläpfer Jürg, Sintra Grilo Liliana, Déglon Jean-Jacques, Besson Jacques, Croquette-Krokar Marina, Carrupt Pierre-Alain, Abriel Hugues, 2008. pp. A6 dans 5th Regensburg Symposium on Clinical Pharmacology, Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_E1A09D2D578F]
 
Suivi thérapeutique des médicaments (I). Les principes [Principles of therapeutic drug monitoring]
Widmer N., Csajka C., Werner D., Grouzmann E., Decosterd L.A., Eap C.B., Biollaz J., Buclin T., 2008. Revue Médicale Suisse, 4 (165) pp. 1644-1668. Peer-reviewed.
[Pmid][serval:BIB_56FB6F49D00F]
 
Suivi thérapeutique des médicaments (II). La pratique clinique [Therapeutic drug monitoring: clinical practice].
Widmer N., Werner D., Grouzmann E., Eap C.B., Marchetti O., Fayet A., Csajka C., Decosterd L.A., Buclin T., 2008. Revue Médicale Suisse, 4 (165) pp. 1649-1660. Peer-reviewed.
[Pmid][serval:BIB_53F56A1C36B3]
2007
 
Clinical consequences of imatinib plasma concentrations variability in hemato-oncologic patients
Widmer N., Leyvraz S., Duchosal M.A., Rosselet A., Csajka C., Henry H., Debiec-Rychter M., Eap C.B., Biollaz J., Buclin T. et al., 2007. p. 481 dans 10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), Therapeutic Drug Monitoring. Peer-reviewed.
[WoS][serval:BIB_6B840EC11A9C]
Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?
Crettol S., Monnat M., Eap C.B., 2007. Critical Care, 11 (1) p. 119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4436790B32FC]
 
CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.
Eap C.B., Bochud M., Elston R.C., Bovet P., Maillard M.P., Nussberger J., Schild L., Shamlaye C., Burnier M., 2007. Hypertension, 49 (5) pp. 1007-14. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_271777C1AEDD]
 
Determination and distribution of clotiapine (Entumine) in human plasma, post-mortem blood and tissue samples from clotiapine-treated patients and from autopsy cases
Sporkert Frank, Augsburger Marc, Giroud Christian, Brossard Clarisse, Eap Chin-Bin, Mangin Patrice, 2007. Forensic Science International, 170 (2/3) pp. 193-199. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_349D98D54E8D]
 
Efficacy and tolerability of quetiapine in cluster B personality disorder: an open-label study
Le Bloc'h Yves, Baumann Pierre, Stigler Michael, Eap Chin-Bin, Zullino Daniele Fabio, 2007. International Journal of Psychiatry in Clinical Practice, 11 (2) pp. 123-128. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F36241EE32C5]
 
In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites
Crettol Séverine, Digon Patricia, Powell Golay Kerry, Brawand Marlyse, Eap Chin-Bin, 2007. Pharmacology, 80 (4) pp. 304-311. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7DD3F39D7F18]
 
Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients
Uehlinger Claude, Crettol Séverine, Chassot Philippe, Brocard Murielle, Koeb Liliane, Brawand-Amey Marlyse, Eap Chin-Bin, 2007. Journal of Clinical Psychopharmacology, 27 (3) pp. 273-278. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14C9CA4BBD65]
 
Micro-cocktail validation for CYP3A and CYP2D6 assessment using a low dose of midazolam (0.075 mg) and dextromethorphan (2.5 mg)
Daali Youssef, Samer C., Eap Chin-Bin, Rebsamen Michaëla, Rossier Michel, Dayer Pierre, Desmeules Jules, 2007. pp. S77-S77 dans , Clinical Pharmacology and Therapeutics. Peer-reviewed.
[DOI][serval:BIB_B5827BA589B8]
 
Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements
Saraeva R. B., Paskaleva I. D., Doncheva E., Eap Chin-Bin, Ganev V. S., 2007. Journal of Clinical Pharmacy and Therapeutics, 32 (6) pp. 641-649. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6255C84E88F0]
 
Pharmacokinetic and pharmacogenetic factors influencing methadone plasma levels
Crettol Séverine, Eap Chin-Bin, 2007. Heroin Addiction and Related Clinical Problems, 9 (2) pp. 39-46. Peer-reviewed.
[serval:BIB_E8D5A9077B7E]
 
Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.
Eap C.B., Crettol S., Rougier J.S., Schläpfer J., Sintra Grilo L., Déglon J.J., Besson J., Croquette-Krokar M., Carrupt P.A., Abriel H., 2007. Clinical Pharmacology and Therapeutics, 81 (5) pp. 719-728. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DBDA92B48C27]
 
The ABCB1 2677 G>T and 3435 C>T variants are associated with glomerular filtration rate in African families [Abstract]
Bochud Murielle, Eap Chin-Bin, Maillard Marc P., Elston Robert C., Bovet Pascal, Shamlaye Conrad, Burnier Michel, 2007. dans Biomedical imaging, CHUV Research Day, February 1, 2007. - Lausanne : CHUV, 2007. - MCV-32, p. 112, CHUV Research Day.
[serval:BIB_1793FC312CF6]
 
Time course of response to paroxetine: influence of plasma level
Gex-Fabry Marianne, Gervasoni Nicola, Eap Chin-Bin, Aubry Jean-Michel, Bondolfi Guido, Bertschy Gilles, 2007. Progress in Neuro-psychopharmacology & Biological Psychiatry, 31 (4) pp. 892-900. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_881B6AF3377A]
2006
 
ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Crettol S., Déglon J.J., Besson J., Croquette-Krokar M., Hämmig R., Gothuey I., Monnat M., Eap C.B., 2006. Clinical pharmacology and therapeutics, 80 (6) pp. 668-81. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D9E02532BEA1]
 
Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity
Stephan P.L., Jaquenoud Sirot E., Mueller B., Eap C.B., Baumann P., 2006. Pharmacopsychiatry, 39 (4) pp. 150-2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD70580355FC]
Apport de la pharmacogénétique dans le traitement médicamenteux des addictions : l'exemple de la méthadone
Eap C.B., Baumann P., 2006. pp. 65-70 dans Suchtforschung des BAG. Recherches de l'OFSP en matière de dépendances 2002-03, Bundesamt für Gesundheit.
[URN][serval:BIB_0953690D575B]
 
Aripiprazole and suicidality.
Holzer L., Eap C.B., 2006. International clinical psychopharmacology, 21 (2) pp. 125-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2FD9DEC2C785]
 
Association of CYP3A5 genotypes with blood pressure and renal function in African families.
Bochud M., Eap C.B., Elston R.C., Bovet P., Maillard M., Schild L., Shamlaye C., Burnier M., 2006. Journal of hypertension, 24 (5) pp. 923-9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2174105C05DE]
 
Dose-dependent venlafaxine-induced hair loss
Jaquenoud Sirot Eveline, Etzensberger M., Eap Chin-Bin, Baumann Pierre, 2006. p. 939 dans , Drug Safety. Peer-reviewed.
[serval:BIB_1AEB8C64710D]
 
Dépendances [Addictions]
Besson J., Eap C., Rougemont-Buecking A., Simon O., Nikolov C., Bonsack C., Gothuey I., 2006. Revue médicale suisse, 2 (47) pp. 9-13. Peer-reviewed.
[Pmid][serval:BIB_86AEDBE730C0]
 
Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status.
Baumann P., Barbe R., Vabre-Bogdalova A., Garran E., Crettol S., Eap C.B., 2006. Journal of clinical psychopharmacology, 26 (6) pp. 679-81. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C2275B85B7A2]
 
Epileptiform seizure following sertraline treatment in an adolescent suffering from obsessive compulsive disorder and presenting a rare pharmacogenetic status
Baumann Pierre, Barbe R., Vabre-Bogdalova A., Garran E., Crettol Séverine, Eap Chin B., 2006. Journal of Clinical Psychopharmacology, 26 (6) pp. 679-681.
[serval:BIB_904321AD6133]
 
Genetic polymorphisms of CYP3A genes affect cyclosporine a blood concentration and dose requirement in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Aubert John-David, Fontana Massimiliano, Brocard Murielle, Pascual Manuel, Eap Chin-Bin, 2006. p. 197 dans NA, Transplantation. Peer-reviewed.
[serval:BIB_1DF48FD34AEB]
 
Influence of MDR1 genetic polymorphisms on intralymphocyte concentrations of cyclosporine A in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Aubert John-David, Fontana Massimiliano, Ansermot Nicolas, Fathi Marc, Brocard Murielle, Pascual Manuel, Eap Chin-Bin, 2006. p. 197 dans NA, Transplantation. Peer-reviewed.
[serval:BIB_2593E2C77971]
 
L’Information psychiatrique
Choong Eva, eap chin, 2006/01/01. Syndrome métabolique et antipsychotiques atypiques: recommandations et prise en charge clinique..
[serval:BIB_3DD17661DFF9]
 
Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.
Colombo S., Buclin T., Décosterd L.A., Telenti A., Furrer H., Lee B.L., Biollaz J., Eap C.B. and , 2006. Clinical pharmacology and therapeutics, 80 (4) pp. 307-18. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_859F62D8CAD6]
 
Pharmacogenomics of opioids
Crettol Séverine, Eap Chin-Bin, 2006. dans Pharmacogenomics and proteomics : enabling the practice of personalized medicine / ed. by Steven H.Y. Wong, Mark W. Linder, Roland Valdes. - Washington, DC : AAC Press, 2006. - P. 187-198. - ISBN 1594250464, NA.
[serval:BIB_2779A49BFF28]
 
Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein
Widmer N., Decosterd L.A., Csajka C., Leyvraz S., Duchosal M.A., Rosselet A., Rochat B., Eap C.B., Henry H., Biollaz J. et al., 2006. British journal of clinical pharmacology, 62 (1) pp. 97-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6058765DDE09]
 
Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening.
Bonsack C., Camus D., Kaufmann N., Aubert A.C., Besson J., Baumann P., Borgeat F., Gillet M., Eap C.B., 2006. Addictive behaviors, 31 (7) pp. 1252-8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD2258F80A77]
 
Relations entre la pharmacocinétique de population de l'imatinib et l'alpha-1-glycoproteine acide chez des patients hémato-oncologiques
Widmer N., Decosterd L.A., Csajka C., Leyvraz S., Duchosal M.A., Rosselet A., Rochat B., Eap C.B., Henry H., Biollaz J. et al., 2006. dans 13es Journées Franco-Suisses de Pharmacie Hospitalière.
[serval:BIB_54B5CDF331B9]
 
Relationship between imatinib population pharmacokinetics and alpha-1-acid glycoprotein
Widmer N., Decosterd L.A., Csajka C., Leyvraz S., Duchosal M.A., Rosselet A., Rochat B., Eap C.B., Henry H., Biollaz J. et al., 2006. pp. 71S dans 74e Assemblée annuelle de la Société Suisse de Médecine Interne (SSMI), Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
[serval:BIB_5CB9DE6BA9E2]
 
Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
Holzer L., Eap C.B., 2006. Journal of clinical psychopharmacology, 26 (2) pp. 167-171. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BC65C3A1135]
 
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.
Jaquenoud Sirot E., van der Velden J.W., Rentsch K., Eap C.B., Baumann P., 2006. Drug safety, 29 (9) pp. 735-768. Peer-reviewed.
[WoS][Pmid][serval:BIB_D30C2EFDB3C6]
2005
 
Association between the CYP3A5 A698G polymorphism and blood pressure in individuals of east African descent
Eap Chin-Bin, Bochud Murielle, Elston Robert C., Bovet Pascal, Maillard Marc P., Burnier Michel, 2005. pp. MCV-042, p. 145 dans , CHUV Research Day.
[serval:BIB_846A5683065D]
 
CYP2D6 genotype in relation to steady state concentrations of mirtazapine, N-desmethylmirtazapine and their enantiomers
Lind A.B., Reis M., Bengtsson Finn, Ahlner Johan, Eap Chin-Bin, Baumann Pierre, Dahl M.L., 2005. p. 124 dans , Basic and Clinical Pharmacology and Toxicology. Peer-reviewed.
[serval:BIB_EB257DCCC0D0]
 
Drug monitoring during substitution treatment
Eap Chin-Bin, 2005. pp. 15-16 dans European Psychiatry. Peer-reviewed.
[serval:BIB_D5920E27A014]
 
Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients.
de Mendonça Lima C.A., Baumann P., Brawand-Amey M., Brogli C., Jacquet S., Cochard N., Powell-Golay K., Eap C.B., 2005. Progress in neuro-psychopharmacology & biological psychiatry, 29 (6) pp. 952-6. Peer-reviewed.
[DOI][Pmid][serval:BIB_B89A5097AC12]
 
Follow-up of a pharmacovigilance study in psychiatry involving TDM and pharmacogenetic testing
Jaquenoud Sirot Eveline, Eap Chin-Bin, Baumann Pierre, 2005. pp. 54-55 dans , Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_3EC852015E30]
 
Genetic polymorphisms of psychotropic drug metabolizing enzymes: clinical relevance
Baumann Pierre, Jaquenoud Eveline, Eap Chin-Bin, 2005. p. 103 dans , European Psychiatry. Peer-reviewed.
[serval:BIB_8AFA09447E4C]
 
High sedation with low doses of atypical antipsychotics in 3 young patients (13 to 14 years old)
Holzer Laurent, Eap Chin-Bin, Halfon Olivier, Baumann Pierre, 2005. p. 53 dans , Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_3EA7258F91FD]
 
Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
Bondolfi G., Morel F., Crettol S., Rachid F., Baumann P., Eap C.B., 2005. Therapeutic drug monitoring, 27 (4) pp. 539-43. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_08E3B822BB7E]
 
Influence of CYP2B6 polymorphism on the steady-state plasma levels of the enantiomers of methadone
Crettol Séverine, Déglon Jean-Jacques, Besson Jacques, Croquette-Krokar Marina, Gottuey I., Haemming R., Monnat Martine, Haottemann H., Baumann Pierre, Eap Chin-Bin, 2005. p. 121 dans NA, Basic and Clinical Pharmacology and Toxicology. Peer-reviewed.
[serval:BIB_87B68E9596B7]
 
Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
Nikisch G., Mathé A.A., Czernik A., Thiele J., Bohner J., Eap C.B., Agren H., Baumann P., 2005. Psychopharmacology, 181 (4) pp. 751-60. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_01B5984DAAF6]
 
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
Crettol S., Déglon J.J., Besson J., Croquette-Krokkar M., Gothuey I., Hämmig R., Monnat M., Hüttemann H., Baumann P., Eap C.B., 2005. Clinical pharmacology and therapeutics, 78 (6) pp. 593-604. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DEE85807A54C]
 
Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.
Nikisch G., Agren H., Eap C.B., Czernik A., Baumann P., Mathé A.A., 2005. International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (cinp), 8 (3) pp. 403-410. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE00FBD3FF24]
 
Optimisation of psychopharmacotherapy: clinical relevance of pharmacogenetic tests and therapeutic drug monitoring
Baumann Pierre, Jaquenoud Sirot Eveline, Eap Chin-Bin, 2005. p. 229 dans , Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_652EBA008707]
 
Pharmacokinetics and pharmacogenetics of methadone : clinical relevance
Eap Chin-Bin, Déglon Jean-Jacques, Baumann Pierre, 2005. dans Heroin-assisted treatment : work in progress / ed. by Margret Rihs-Middel...[et al.]. - Bern : H. Huber, 2005. - P. 251-265. - ISBN 3-456-83899-9.
[serval:BIB_259C666AFF75]
 
Plasma-CSF concentrations relationship of psychotropic drugs
Baumann Pierre, Nikisch Georg, Eap Chin-Bin, 2005. p. 43 dans , Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_91DED83B98B8]
 
Prevalence of methadone injection in three Swiss cities.
Chevalley A.E., Besson J., Croquette-Krokar M., Davidson C., Dubois J.A., Uehlinger C., Eap C.B., 2005. Presse Médicale, 34 (11) pp. 776-780. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_988B654EAA53]
 
Severe bruising as an adverse event: chocolate or fluvoxamine? Case report
Jaquenoud Sirot Eveline, Stephan P.L., Baumann Pierre, 2005. p. 55 dans , Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_E9EF72CAB015]
 
TDM and pharmacogenetic tests as tools in pharmacovigilance: case reports
Jaquenoud Sirot Eveline, Stephan P., Knezevic B., Eap Chin-Bin, Baumann Pierre, 2005. p. 54 dans , Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_AAA2A3FCC32F]
 
The CYP3A5 polymorphism is associated with ambulatory blood pressure increase with age in families of African descent
Bochud Murielle, Eap Chin-Bin, Elston Robert C., Bovet Pascal, Schild Laurent, Maillard Marc P., Burnier Michel, 2005. p. 367 dans , Journal of Hypertension. Peer-reviewed.
[serval:BIB_D82BF9E3E810]
 
The CYP3A5 polymorphism is associated with urinary sodium excretion in families of African descent
Bochud Murielle, Elston Robert C., Bovet Pascal, Schild Laurent, Maillard Marc P., Burnier Michel, Eap Chin-Bin, 2005. p. 364 dans , Journal of Hypertension. Peer-reviewed.
[serval:BIB_98D57AC04240]
 
Therapeutic drug monitoring of psychotropic drugs in the era of pharmacogenetics studies
Eap Chin-Bin, 2005. pp. 208-209 dans European Psychiatry. Peer-reviewed.
[serval:BIB_38337EE9B5B9]
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients.
Fellay J., Marzolini C., Decosterd L., Golay K.P., Baumann P., Buclin T., Telenti A., Eap C.B., 2005. European journal of clinical pharmacology, 60 (12) pp. 865-73. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7E60EAA242E4]
 
Will genotyping and phenotyping methods replace TDM in the future?
Eap Chin-Bin, Baumann Pierre, 2005. p. 48 dans , Pharmacopsychiatry. Peer-reviewed.
[DOI][serval:BIB_03434079A45B]
2004
A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry(HILIC-MS).
Giroud C., Michaud K., Sporkert F., Eap C., Augsburger M., Cardinal P., Mangin P., 2004/09. Journal of analytical toxicology, 28 (6) pp. 464-474. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_39968532E823]
 
CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter gene.
Eap C.B., Fellay J., Buclin T., Bleiber G., Golay K.P., Brocard M., Baumann P., Telenti A., 2004/04. Pharmacogenetics, 14 (4) pp. 255-260. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0DA344954504]
 
Apport de la pharmacogénétique dans la prise en charge médicamenteuse des addictions
Eap Chin-Bin, 2004. THS : la revue des addictions, 6 (23) pp. 1173-1175.
[serval:BIB_150DACBF3F02]
 
Apport de la pharmacogénétique dans la prise en charge médicamenteuse des addictions
Eap Chin-Bin, 2004. dans Addictions et toxicomanie : actes du colloque THS6 toxicomanies, hépatites, sida / sous la dir. de Jean-Marie Guffens. - Paris : Frison-Roche, 2004. - P. 103-108. - ISBN 2-87671-457-4.
[serval:BIB_BBE58992BFDE]
 
Chirality in the new generation of antidepressants: stereoselective analysis of the enantiomers of mirtazapine, N-demethylmirtazapine, and 8-hydroxymirtazapine by LC-MS.
Paus E., Jonzier-Perey M., Cochard N., Eap C.B., Baumann P., 2004. Therapeutic drug monitoring, 26 (4) pp. 366-74. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_08C2D1EDB8C8]
 
Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
Ciusani E., Zullino D.F., Eap C.B., Brawand-Amey M., Brocard M., Baumann P., 2004. Journal of Psychopharmacology, 18 (4) pp. 559-566. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F19B17FFEA0]
 
Death following acute poisoning by moclobemide
Giroud C., Horisberger B., Eap C., Augsburger M., Ménétrey A., Baumann P., Mangin P., 2004. Forensic science international, 140 (1) pp. 101-107. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D1D5C6BC8350]
 
Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometry.
Eap C.B., Bouchoux G., Scherbaum N., Gastpar M., Powell Golay K., Baumann P., 2004. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 805 (1) pp. 141-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13E0AC4AC22B]
 
Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography-negative chemical ionization-mass spectrometry.
Eap C.B., Bouchoux G., Powell Golay K., Baumann P., 2004. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 802 (2) pp. 339-45. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE65337BE312]
 
Die Bedeutung der Pharmakogenetik für die Psychopharmakotherapie
Baumann Pierre, Eap Chin-Bin, Jaquenoud Sirot Eveline, 2004. p. 322 dans , Der Nervenarzt. Peer-reviewed.
[serval:BIB_B2DAEB8AEEE4]
 
Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone
Benmebarek M., Devaud C., Gex-Fabry M., Powell Golay K., Brogli C., Baumann P., Gravier B., Eap C.B., 2004. Clinical pharmacology and therapeutics, 76 (1) pp. 55-63. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19CBC2A79031]
 
Follow-up study using TDM and pharmacogenetic testing as tools in pharmacovigilance
Jaquenoud Sirot Eveline, Eap Chin-Bin, Baumann Pierre, 2004. pp. 937-937 dans , Drug Safety. Peer-reviewed.
[serval:BIB_91F8CD54B693]
 
High dose of depot risperidone in a nonresponder schizophrenic patient.
Albrecht A., Morena P.G., Baumann P., Eap C.B., 2004. Journal of clinical psychopharmacology, 24 (6) pp. 673-4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CBC5ED96D91D]
 
High-dose venlafaxine treatment in a depressed patient with a genetic CYP2D6 deficiency
Haller-Gloor Friedrich, Eap Chin-Bin, Turgeon Jacques, Baumann Pierre, 2004. International Journal of Psychiatry in Clinical Practice, 8 (3) pp. 191-195. Peer-reviewed.
[DOI][WoS][serval:BIB_6E2A987DD383]
 
Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene.
Eap C.B., Bender S., Jaquenoud Sirot E., Cucchia G., Jonzier-Perey M., Baumann P., Allorge D., Broly F., 2004. Journal of clinical psychopharmacology, 24 (2) pp. 214-9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9A6B745D07B0]
Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.
Eap C.B., Buclin T., Cucchia G., Zullino D., Hustert E., Bleiber G., Golay K.P., Aubert A.C., Baumann P., Telenti A. et al., 2004. European journal of clinical pharmacology, 60 (4) pp. 237-46. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9381D46D9A28]
Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects
Eap C.B., Buclin T., Hustert E., Bleiber G., Golay K.P., Aubert A.C., Baumann P., Telenti A., Kerb R., 2004. European journal of clinical pharmacology, 60 (4) pp. 231-236. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C414875FF528]
 
Pharmacovigilance study in psychiatry involving TDM and pharmacogenetics
Jaquenoud Sirot Eveline, Eap Chin-Bin, Baumann Pierre, 2004. pp. I/22 dans , European Archives of Psychiatry and Clinical Neuroscience. Peer-reviewed.
[DOI][serval:BIB_EA4B30B44541]
 
Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.
Nikisch G., Mathé A.A., Czernik A., Eap C.B., Jiménez-Vasquez P., Brawand-Amey M., Baumann P., 2004. Journal of clinical psychopharmacology, 24 (3) pp. 283-90. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D78E07AD532B]
 
The role of pharmacogenetics in the pharmacological treatment of psychiatric disorders
Eap Chin-Bin, Baumann Pierre, 2004. pp. I/13 dans , European Archives of Psychiatry and Clinical Neuroscience. Peer-reviewed.
[DOI][serval:BIB_915122CE6631]
 
Therapeutic drug monitoring and pharmacogenetics of psychotropic drugs
Baumann Pierre, Jaquenoud Sirot Eveline, Eap Chin-Bin, 2004. p. 116 dans , Clinical Chemistry and Laboratory Medicine. Peer-reviewed.
[serval:BIB_43E0D72CC77A]
 
Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.
Eap C.B., Jaquenoud Sirot E., Baumann P., 2004. Therapeutic drug monitoring, 26 (2) pp. 152-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B10CB1D7C7A6]
2003
 
Automated LC-MS method for the fast stereoselective determination of methadone in plasma
Souverain Sandrine, Eap Chin-Bin, Veuthey Jean-Luc, Rudaz Serge, 2003. Clinical Chemistry and Laboratory Medicine, 41(12) pp. 1615-1621. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B436A2EB08F0]
 
Bedeutung von TDM und Pharmakogenetik bei Untersuchungen über Arzneimittelsicherheit in der Psychiatrie
Jaquenoud Sirot Eveline, Eap Chin-Bin, Baumann Pierre, 2003. Psychopharmakotherapie, 10 (1) pp. 5-10. Peer-reviewed.
[WoS][serval:BIB_B1D6E3D82BD3]
 
Can therapeutic drug monitoring and pharmacogenetic tests provide tools in pharmacovigilance ?
Jaquenoud Sirot Eveline, Eap Chin-Bin, Baumann Pierre, 2003. p. 234 dans , Pharmacoepidemiology and Drug Safety. Peer-reviewed.
[serval:BIB_692214C12A1D]
 
Clinical outcome after trimipramine in patients with delusional depression - a pilot study
Frieboes R.M., Sonntag A., Yassouridis A., Eap C.B., Baumann P., Steiger A., 2003. Pharmacopsychiatry, 36 (1) pp. 12-17. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3507036DFB38]
 
Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses.
Shinderman M., Maxwell S., Brawand-Amey M., Golay K.P., Baumann P., Eap C.B., 2003. Drug and alcohol dependence, 69 (2) pp. 205-11. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50BEAD87FFE3]
 
Effect of the CYP3A4 inhibitor ketoconazol on the pharmacokinetics of mirtazapine in healthy volunteers
Baumann Pierre, Van Den Heuvel Wim J.A., Sisten J.M.A., Eap Chin-Bin, Peeters P.A.M., 2003. p. 241 dans , European Neuropsychopharmacology. Peer-reviewed.
[serval:BIB_92525ABA3A9B]
 
Identification of a novel splice-site mutation in the CYP1A2 gene.
Allorge D., Chevalier D., Lo-Guidice J.M., Cauffiez C., Suard F., Baumann P., Eap C.B., Broly F., 2003. British journal of clinical pharmacology, 56 (3) pp. 341-4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45CA4F4DA728]
 
Increase of oral methadone dose in methadone injecting patients: a pilot study
Eap Chin-Bin, Felder C., Powell Golay Kerry Jane, Uehlinger Claude, 2003. Journal of Addictive Diseases, 22 (3) pp. 7-17. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D89EDE4E0578]
 
Influence of metabolic processes on course and treatment of opioid-dependence
Eap Chin-Bin, Baumann Pierre, 2003. p. 222 dans , Pharmacopsychiatry. Peer-reviewed.
[serval:BIB_E07985BB7780]
 
Interactions between somatic and psychotic drugs: pharmacokinetic and pharmacodynamic consequences
Baumann Pierre, Jaquenoud Sirot Eveline, Eap Chin-Bin, 2003. p. 213 dans , Pharmacopsychiatry. Peer-reviewed.
[serval:BIB_24118335CA39]
 
Methadone maintenance treatment and St. John's Wort - a case report.
Eich-Höchli D., Oppliger R., Golay K.P., Baumann P., Eap C.B., 2003. Pharmacopsychiatry, 36 (1) pp. 35-7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_33959DD0A326]
 
Pharmacologie clinique et pharmacogénétique de la méthadone
Eap Chin-Bin, Baumann Pierre, 2003. dans Suchtforschung des BAG 1999-2001. Bd 1/3, Grundlagenforschung = Recherches de l'OFSP en matière de dépendances 1999-2001. Vol. 1/3, Recherche fondamentale / Schweiz. Bundesamt für Gesundheit Hrsg. - Bern : BAG (Bundesamt für Gesundheit), 2003. - P. 52-57.
[serval:BIB_1326C19B432B]
 
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.
Eap C.B., Lessard E., Baumann P., Brawand-Amey M., Yessine M.A., O'Hara G., Turgeon J., 2003. Pharmacogenetics, 13 (1) pp. 39-47. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ADD5D6E0F8D6]
 
Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram
Le Bloc'h Y., Woggon B., Weissenrieder H., Brawand-Amey M., Spagnoli J., Eap C.B., Baumann P., 2003. Therapeutic drug monitoring, 25 (5) pp. 600-608. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9D1DA1CE4C14]
 
Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test
Melichar J.K., Myles J.S., Eap Chin-Bin, Nutt David J., 2003. Addiction Biology, 8 (1) pp. 59-66. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A469528CE792]
2002
 
Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study
Steinacher L., Vandel P., Zullino D.F., Eap C.B., Brawand-Amey M., Baumann P., 2002. European Neuropsychopharmacology, 12 (3) pp. 255-260. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_838EF92A0522]
 
Chiral psychotropic drugs: TDM and pharmacogenetics
Baumann Pierre, Eap Chin-Bin, 2002. pp. VIII dans , Pharmacopsychiatry. Peer-reviewed.
[serval:BIB_9736956EFCF9]
 
Compliance testing by routine TDM of psychotropic drugs: some observations and methodological issues
Baumann Pierre, Brawand Marlyse, Brocard Murielle, Cochard Nathalie, Jaquet S., Jonzier Perey Michèle, Koeb Liliane, Powell Kerry Jane, Eap Chin-Bin, 2002. pp. IV dans , Pharmacopsychiatry. Peer-reviewed.
[serval:BIB_940C30E1A031]
 
CYP2C19 dependent pharmacogenetics of (S)- and (R)-citalopram
Baumann Pierre, Nil Rico, Souche A., Brawand-Amey Marlyse, Jonzier Perey Michèle, Eap Chin-Bin, 2002. p. 243 dans , International Journal of Psychiatry in Clinical Practice. Peer-reviewed.
[DOI][serval:BIB_765E46791AD4]
 
Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.
Wikell C., Eap C.B., Josefsson M., Apelqvist G., Ahlner J., Baumann P., Bengtsson F., 2002. Chirality, 14 (4) pp. 347-350. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7655A9D32B64]
 
Drug metabolism of antipsychotics and clinical consequenses
Baumann Pierre, Zullino Daniele Fabio, Eap Chin-Bin, 2002. p. 14 dans , European Psychiatry. Peer-reviewed.
[serval:BIB_7E9B576A2C3D]
 
Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram
Baumann P., Zullino D.F., Eap C.B., 2002. European Neuropsychopharmacology, 12 (5) pp. 433-444. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9A46169C70F8]
 
Industrial and regulatory perspectives on the development of psychotropic drug enantiomers
Baumann Pierre, Eap Chin-Bin, Paus Erik, Zullino Daniele, 2002. p. 50 dans , International Journal of Neuropsychopharmacology. Peer-reviewed.
[DOI][serval:BIB_86E42C76BCB7]
 
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence
Eap C.B., Buclin T., Baumann P., 2002. Clinical pharmacokinetics, 41 (14) pp. 1153-1193. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_520812777D83]
 
Multidrug resistance and response to antiretroviral treatment - Reply
Fellay J., Back D., Schinkel A.H., Eap C.B., Telenti A., 2002. The Lancet, 359 (9323) pp. 2114-2115.
[DOI][WoS][serval:BIB_98360C7D4895]
 
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers
Begré S., von Bardeleben U., Ladewig D., Jaquet-Rochat S., Cosendai-Savary L., Golay K.P., Kosel M., Baumann P., Eap C.B., 2002. Journal of clinical psychopharmacology, 22 (2) pp. 211-215. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A970376E12E5]
 
Pharmacogenetics of chiral psychotropic drugs
Baumann Pierre, Eap Chin-Bin, 2002. dans Pharmacogenetics of psychotropic drugs / ed. by Bernard Lerer. - Cambridge : Cambridge University Press, cop. 2002. - P. 181-214. - ISBN 0521806178.
[serval:BIB_78252F3F932C]
 
Pharmakokinetik und therapeutisches Monitoring von Antidepressiva
Baumann Pierre, Zullino Daniele, Eap Chin-Bin, 2002. dans Depression 2000 / G. Laux Hrsg. - Berlin [etc.] : Springer, 2002. - P. 37-49.
[serval:BIB_658B2AE2B594]
 
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Fellay J., Marzolini C., Meaden E.R., Back D.J., Buclin T., Chave J.P., Decosterd L.A., Furrer H., Opravil M., Pantaleo G. et al., 2002. The Lancet, 359 (9300) pp. 30-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_15EF32DDF0CC]
 
TDM and pharmacogenetics as tools in pharmacovigilance: methodological aspects
Jaquenoud Sirot Eveline, Eap Chin-Bin, Baumann Pierre, 2002. pp. VIII dans , Pharmacopsychiatry. Peer-reviewed.
[serval:BIB_2C998FF0F77C]
 
The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients
Bondolfi G., Eap C.B., Bertschy G., Zullino D., Vermeulen A., Baumann P., 2002. Pharmacopsychiatry, 35 (2) pp. 50-56. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8AACDA39626E]
 
Therapy with antidepressants: pharmacogenetic aspects
Baumann Pierre, Zullino Daniele Fabio, Jaquenoud Sirot Eveline, Paus Erik, Eap Chin-Bin, 2002. dans Perspectives in affective disorders / International Symposium "25 Years Weissenau Depression Unit" Weissenau, Germany, September 14-15, 2001 ; volume editor, W.P. Kaschka. - Basel ; New York : Karger, 2002. - P. 95-111. - (Advances in biological psychiatry ; vol. 21).
[DOI][serval:BIB_5666A90E15E6]
 
Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine
Zullino D.F., Delessert D., Eap C.B., Preisig M., Baumann P., 2002. International clinical psychopharmacology, 17 (3) pp. 141-143. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E52523D88082]
 
Variabilité interindividuelle de la réponse thérapeutique aux médicaments de substitution : le cas de la méthadone
Eap Chin-Bin, 2002. dans Dans le secret des drogues et des virus : Actes du colloque THS 5, Grasse 2001, toxicomanies, hépatites, SIDA / sous la dir. de Jean-Marie Guffens. - Paris : Frison-Roche, 2002. - P. 149-157. - ISBN 978-2876714076.
[serval:BIB_5A12F027981D]
 
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer
Hilleret H., Voirol P., Bovier P., Giannakopoulos P., Zullino D., Baumann P., Giroud C., Rivier L., Eap C.B., 2002. Therapeutic drug monitoring, 24 (4) pp. 567-569. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A9FB304D3F98]
2001
 
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers.
Eap C.B., Bondolfi G., Zullino D., Savary-Cosendai L., Powell-Golay K., Kosel M., Baumann P., 2001. Journal of clinical psychopharmacology, 21 (3) pp. 330-4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4CEBF01F1F92]
 
Cytochrome P450 2D6 genotype and methadone steady-state concentrations
Eap C.B., Broly F., Mino A., Hämmig R., Déglon J.J., Uehlinger C., Meili D., Chevalley A.F., Bertschy G., Zullino D. et al., 2001. Journal of clinical psychopharmacology, 21 (2) pp. 229-234. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7A0AF50871FA]
 
Enantiomeric antidepressant drugs should be considered on individual merit
Baumann P., Eap C.B., 2001. Human psychopharmacology, 16 (S2) pp. S85-S92. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_401A37C08A28]
 
Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations
Baumann P., Eap C.B., Zullino D.F., 2001. Journal of Nervous and Mental Disease, 189 (11) pp. 798-799. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_77B3B53AFD2A]
 
Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir.
Bart P.A., Rizzardi P.G., Gallant S., Golay K.P., Baumann P., Pantaleo G., Eap C.B., 2001. Therapeutic drug monitoring, 23 (5) pp. 553-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5E69B13DE248]
 
Ondansetron for tardive dyskinesia
Zullino Daniele Fabio, Eap Chin-Bin, Voirol Pierre, 2001. American Journal of Psychiatry, 158 (4) pp. 657-658. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A2DF1B800180]
 
Pharmacokinetic consequences of a carbamazepine augmentation in depressive patients non-responding to citalopram: stereoselective aspects
Steinacher Lina, Vandel Pierre, Zullino Daniele Fabio, Eap Chin-Bin, Brawand-Amey Marlyse, Baumann Pierre, 2001. p. 203 dans , Pharmacopsychiatry. Peer-reviewed.
[serval:BIB_42E08B87043E]
 
Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test.
Eap C.B., Bondolfi G., Zullino D., Bryois C., Fuciec M., Savary L., Jonzier-Perey M., Baumann P., 2001. Therapeutic drug monitoring, 23 (3) pp. 228-231. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0BC34D8C888F]
 
Prescription des antidépresseurs chez la personne âgée : à propos de quelques spécificités
Eap Chin-Bin, Voirol Pierre, Baumann Pierre, Lima Carlos Augusto de Mendonça, 2001. dans La dépression : perspectives en psychiatrie de la personne âgée / réd. en chef Vincent Camus, Laurent Schmitt . - Paris : Serdi, 2001. - P. 131-150.
[serval:BIB_FC8462F74D4F]
 
Present evidence of psychotropic drug metabolism in brain and its possible clinical relevance
Baumann Pierre, Voirol Pierre, Kosel Markus, Porchet F., Bouras Constantin, Eap Chin-Bin, 2001. p. 164 dans , World Journal of Biological Psychiatry. Peer-reviewed.
[serval:BIB_89525332B5A8]
 
Therapeutic monitoring of chiral psychotropic drugs
Baumann Pierre, Paus Erik, Powell Kerry Jane, Brawand-Amey Marlyse, Eap Chin-Bin, 2001. p. 164 dans , World Journal of Biological Psychiatry. Peer-reviewed.
[serval:BIB_8D802D5C2123]
2000
 
Rapid remission of depression after carbamazepine augmentation of venlafaxine
European Psychiatry (eds.), 2000/10., 15 S2.
[DOI][serval:BIB_C03A3EC8A0B6]
 
Comment: opiate withdrawal symptoms induced by antiretroviral drugs.
Eap C.B., 2000. Annals of Pharmacotherapy, 34 (9) pp. 1077-1078. Peer-reviewed.
[WoS][Pmid][serval:BIB_F78BB0933A18]
 
Cytochrome P-450 activities in human and rat brain microsomes.
Voirol P., Jonzier-Perey M., Porchet F., Reymond M.J., Janzer R.C., Bouras C., Strobel H.W., Kosel M., Eap C.B., Baumann P., 2000. Brain research, 855 (2) pp. 235-43. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6EB25387D963]
 
Drug metabolism by cytochrome P-450 in human and rat brain microsomes
Voirol P., Jonzier Perey M., Porchet F., Reymond M.J., Janzer R.C., Bouras C., Strobel H.W., Kosel M., Eap C.B., Baumann P., 2000. pp. S95-S96 dans 13th Congress of the European College of Neuropsychopharmacology, European Neuropsychopharmacology. Peer-reviewed.
[serval:BIB_1457930F9C51]
 
Efavirenz decreases methadone blood concentrations.
Marzolini C., Troillet N., Telenti A., Baumann P., Decosterd L.A., Eap C.B., 2000. AIDS, 14 (9) pp. 1291-1292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3264B6C2D4B7]
 
Fluoxetine augmentation in citalopram non-responders: pharmacokinetic and clinical consequences.
Bondolfi G., Lissner C., Kosel M., Eap C.B., Baumann P., 2000. International Journal of Neuropsychopharmacology, 3 (1) pp. 55-60. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F792F8B6CFA0]
 
La psychopharmacothérapie dans le domaine de la psychogériatrie: actualité, problèmes, perspectives [Psychopharmacology in the psychogeriatric domain: current data, problems, perspectives]
Lima C.A., Eap C.B., Baumann P., 2000. Revue médicale de la Suisse romande, 120 (2) pp. 131-6.
[Pmid][serval:BIB_6D844F0693C1]
 
Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: a case report.
Eap C.B., Bertel-Laubscher R., Zullino D., Amey M., Baumann P., 2000. Pharmacopsychiatry, 33 (3) pp. 112-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D919692A88B3]
 
Monitoring thérapeutique des psychotropes et tests pharmacogénétiques en psychiatrie [Therapeutic monitoring of psychotropic drugs and pharmacogenetic tests in psychiatry]
Voirol P., Eap C.B., Baumann P., 2000. Revue médicale de la Suisse romande, 120 (2) pp. 99-104.
[Pmid][serval:BIB_E8B8D250E379]
 
Nouvelles études psychopharmacologiques sur la méthadone: implications pour le traitement de la dépendance aux opiaces
Eap Chin-Bin, 2000. Revue médicale de la Suisse romande, 120 (2) pp. 111-116.
[Pmid][serval:BIB_2CE99757EA83]
 
On the usefulness of therapeutic drug monitoring of methadone
Eap Chin-Bin, 2000. European Addiction Research, 6 (1) pp. 31-33. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BC51E3FDCFE7]
 
Pharmacocinétique et pharmacogénétique de la méthadone
Eap Chin-Bin, Baumann Pierre, 2000. dans Suchtforschung des BAG 1996-98. Bd. 1/4, Grundlagenforschung = Recherches de l'OFSP en matière de dépendances 1996-98. Vol. 1/4, Recherche fondamentale / [éd. Bundesamt für Gesundheit (BAG)] . - Bern : BAG, 2000. - P. 16-19.
[serval:BIB_235903DE1ECD]
 
Pharmacokinetic drug interaction potential of risperidone as assessed by the dextromethorphan, the caffeine and the mephenytoin test
Eap Chin-Bin, Bondolfi Guido, Zullino Daniele Fabio, Bryois Christian, Fuciec Manuela, Savary Line, Jonzier Perey Michèle, Baumann Pierre, 2000. pp. 394-395 dans , European Psychiatry. Peer-reviewed.
[serval:BIB_E1478A1D3C5D]
 
Pharmacokinetics of methadone and LAAM, and their clinical relevance
Eap Chin-Bin, Baumann Pierre, 2000. p. 238 dans , European Psychiatry. Peer-reviewed.
[serval:BIB_7D3EB07627F5]
 
Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment
Eap C.B., Bourquin M., Martin J., Spagnoli J., Livoti S., Powell K., Baumann P., Déglon J., 2000. Drug and alcohol dependence, 61 (1) pp. 47-54. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D9AFA531780D]
 
Sehr hohe CYP1A2-Aktivität und Nonresponse auf Clozapin
Benders S., Eap Chin-Bin, Baumann Pierre, Gastpar Markus, 2000. p. 137 dans , Der Nervenarzt. Peer-reviewed.
[serval:BIB_C51DA9E8114B]
 
Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients.
Eap C.B., Bender S., Gastpar M., Fischer W., Haarmann C., Powell K., Jonzier-Perey M., Cochard N., Baumann P., 2000. Therapeutic drug monitoring, 22 (2) pp. 209-14. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57B4E4E6B2D8]
 
When "enough" is not enough: new perspectives on optimal methadone maintenance dose.
Leavitt S.B., Shinderman M., Maxwell S., Eap C.B., Paris P., 2000. Mount Sinai Journal of Medicine, New York, 67 (5-6) pp. 404-411. Peer-reviewed.
[WoS][Pmid][serval:BIB_900CFA9AA758]
1999
 
Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and of its metabolites.
Eap C.B., Yasui N., Kaneko S., Baumann P., Powell K., Otani K., 1999. Therapeutic Drug Monitoring, 21 (2) pp. 166-170. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8F88B301895B]
 
Oral and intravenous methadone use: some clinical and pharmacokinetic aspects.
Felder C., Uehlinger C., Baumann P., Powell K., Eap C.B., 1999. Drug and Alcohol Dependence, 55 (1-2) pp. 137-143. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A8A466938836]
 
The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine.
Fjordside L., Jeppesen U., Eap C.B., Powell K., Baumann P., Brøsen K., 1999. Pharmacogenetics, 9 (1) pp. 55-60. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8A7E2096B5D1]
1998
 
Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers
Eap C. B., Schnyder C., Besson J., Savary L., Buclin T., 1998/07. Clinical Pharmacology and Therapeutics, 64 (1) pp. 52-7.
[DOI][WoS][Pmid][serval:BIB_DA7319DC4240]
 
Multiple and simultaneous phenotyping tests: beware of ascorbic acid when determining the mephenytoin (S)/(R) ratio
Eap C. B., Buclin T., Buchwalder P. A., Gutmann N., Baumann P., 1998/03. Clinica Chimica Acta, 271 (1) pp. 105-7.
[WoS][Pmid][serval:BIB_4A3727F49FA6]
 
Steady State Concentrations of the Enantiomers of Mianserin and Desmethylmianserin in Poor and in Homozygous and Heterozygous Extensive Metabolizers of Debrisoquine
Eap Chin B., de Mendonça Lima Carlos A., Macciardi Fabio, Woggon Brigitte, Powell Kerry, Baumann Pierre, 1998/02. Therapeutic Drug Monitoring, 20 (1) pp. 7-13. Peer-reviewed.
[DOI][WoS][serval:BIB_DDE855695869]
 
Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography.
Kosel M., Eap C.B., Amey M., Baumann P., 1998. Journal of Chromatography. B, Biomedical Sciences and Applications, 719 (1-2) pp. 234-238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_78BA074FA16B]
 
Determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma by gas chromatography--mass spectrometry.
Eap C.B., Schnyder C., Savary L., 1998. Journal of Chromatography. B, Biomedical Sciences and Applications, 705 (1) pp. 139-144. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_397A140A650F]
 
High interindividual variability of methadone enantiomer blood levels to dose ratios.
Eap C.B., Bertschy G., Baumann P., Finkbeiner T., Gastpar M., Scherbaum N., 1998. Archives of General Psychiatry, 55 (1) pp. 89-90. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1FAC497F9169]
 
Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
Bondolfi G., Dufour H., Patris M., May J.P., Billeter U., Eap C.B., Baumann P., 1998. American Journal of Psychiatry, 155 (4) pp. 499-504. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_95936BB3515C]
Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
Eap C.B., Bouchoux G., Amey M., Cochard N., Savary L., Baumann P., 1998. Journal of Chromatographic Science, 36 (7) pp. 365-371. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EC8181B87934]
 
Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping.
Baumann P., Broly F., Kosel M., Eap C.B., 1998. Pharmacopsychiatry, 31 (2) p. 72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B28B3C20DDC3]
 
Very High Cytochrome P4501A2 Activity and Nonresponse to Clozapine
Bender S., Eap C.B., 1998. Archives of General Psychiatry, 55 (11) pp. 1048-1050. Peer-reviewed.
[serval:BIB_B5085994B07A]
1997
 
Determination of the Enantiomers of Mianserin and its Metabolites in Plasma by Capillary Electrophoresis After Liquid--Liquid Extraction and On-Column Sample Preconcentration
Eap C. B., Powell K., Baumann P., 1997/07/01. Journal of Chromatographic Science, 35 (7) pp. 315-320. Peer-reviewed.
[DOI][serval:BIB_D0DBC2323996]
 
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.
Eap C.B., Bertschy G., Powell K., Baumann P., 1997. Journal of Clinical Psychopharmacology, 17 (2) pp. 113-117. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_654FBC87007F]
 
Galactorrhoea induced by a pharmacodynamic interaction between citalopram, alprazolam and tramadol: a case report.
Bondolfi G., Rubin C., Bryois C., Eap C.B., 1997. Thérapie, 52 (1) pp. 76-77.
[WoS][Pmid][serval:BIB_1253325E934D]
1996
 
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
Eap C.B., Baumann P., 1996. Journal of Chromatography. B, Biomedical Applications, 686 (1) pp. 51-63. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB1A5F818C7D]
 
Fluoxetine addition to methadone in addicts: pharmacokinetic aspects.
Bertschy G., Eap C.B., Powell K., Baumann P., 1996. Therapeutic Drug Monitoring, 18 (5) pp. 570-572. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D3FB791D7AF]
 
Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
Conus P., Bondolfi G., Eap C.B., Macciardi F., Baumann P., 1996. Pharmacopsychiatry, 29 (3) pp. 108-110.
[DOI][WoS][Pmid][serval:BIB_41FCDBF3455A]
 
Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin.
Eap C.B., Guentert T.W., Schãublin-Loidl M., Stabl M., Koeb L., Powell K., Baumann P., 1996. Clinical Pharmacology and Therapeutics, 59 (3) pp. 322-331. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_227FD9136C7D]
 
Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics.
Eap C.B., Finkbeiner T., Gastpar M., Scherbaum N., Powell K., Baumann P., 1996. European Journal of Clinical Pharmacology, 50 (5) pp. 385-389. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E37ACB0474F]
 
Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry.
Eap C.B., Gaillard N., Powell K., Baumann P., 1996. Journal of Chromatography. B, Biomedical Applications, 682 (2) pp. 265-272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6B76DED99984]
 
Two-step chromatographic purification of human plasma alpha(1)-acid glycoprotein: its application to the purification of rare phenotype samples of the protein and their study by chromatography on immobilized metal chelate affinity adsorbent.
Herve F., Millot M.C., Eap C.B., Duche J.C., Tillement J.P., 1996. Journal of Chromatography. B, Biomedical Applications, 678 (1) pp. 1-14. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A8ED21664DA3]
1995
 
Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma.
Eap C.B., Koeb L., Powell K., Baumann P., 1995. Journal of Chromatography. B, Biomedical Applications, 669 (2) pp. 271-279. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CA4F40BC646A]
 
Plasmaspiegelbestimmungen von chiralen Psychopharmaka
Baumann Pierre, Eap Chin B., 1995. Psychopharmakotherapie, 2 (1) pp. 29-30.
[serval:BIB_721F2F0940E0]
1994
 
Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients.
Eap C.B., Powell K., Campus-Souche D., Monney C., Baettig D., Taeschner W., Baumann P., 1994. Chirality, 6 (7) pp. 555-563. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA1DBEFAB0B0]
 
Determination of trimipramine and its demethylated and hydroxylated metabolites in plasma by gas chromatography-mass spectrometry.
Eap C.B., Koeb L., Baumann P., 1994. Journal of Chromatography, 652 (1) pp. 97-103. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C2C3D83016F6]
 
Increased trimipramine plasma levels during fluvoxamine comedication.
Seifritz E., Holsboer-Trachsler E., Hemmeter U., Eap C.B., Baumann P., 1994. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 4 (1) pp. 15-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D760250B190B]
 
Influence of amesergide treatment on the dextromethorphan test.
Baumann P., Hatzinger M., Hemmeter U., Seifritz E., Eap C.B., Holsboer E., 1994. British Journal of Clinical Pharmacology, 38 (2) pp. 151-152. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_969F40621D17]
 
Probable metabolic interaction between methadone and fluvoxamine in addict patients.
Bertschy G., Baumann P., Eap C.B., Baettig D., 1994. Therapeutic Drug Monitoring, 16 (1) pp. 42-45. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5A88CEFC3C63]
1993
 
Artifacts in the analysis of thioridazine and other neuroleptics.
Eap C.B., Koeb L., Baumann P., 1993. Journal of Pharmaceutical and Biomedical Analysis, 11 (6) pp. 451-457. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24DDAEF23706]
 
Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography-mass spectrometry.
Reymond P., Amey M., Souche A., Lambert S., Konrat H., Eap C.B., Baumann P., 1993. Journal of Chromatography, 616 (2) pp. 221-228. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_877B784FDB7D]
 
Klinische Relevanz pharmakogenetischer Phänotypiserungen
Baumann Pierre, Eap Chin B., 1993. pp. 658-663 dans Baumann P., Fleischhacker W. W., Gaebel W., Laux G., Möller H. J., Saletu B., Woggon B. (eds.) Biologische Psychiatrie der Gegenwart. 3. Drei-Länder Symposium für Biologische Psychiatrie, Lausanne, September 1992., Springer-Verlag.
[serval:BIB_283B66068FA1]
 
Orosomucoid system: 17 additional orosomucoid variants and proposal for a new nomenclature.
Yuasa I., Weidinger S., Umetsu K., Suenaga K., Ishimoto G., Eap B.C., Duche J.C., Baumann P., 1993. Vox Sanguinis, 64 (1) pp. 47-55. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1DAF9B2421E6]
 
The a 1-acid clycoprotein: structure and possible functions in the acute phase response
Eap Chin B., Baumann Pierre, 1993. pp. 107-116 dans Mackiewicz A., Kushner I., Baumann H. (eds.) Acute phase proteins. Molecular biology, biochemistry, and clinical application, CRC Press.
[serval:BIB_BCDE954D4293]
1992
 
Influence of quinidine on the pharmacokinetics of trimipramine and on its effect on the waking EEG of healthy volunteers. A pilot study on two subjects.
Eap C.B., Laurian S., Souche A., Koeb L., Reymond P., Buclin T., Baumann P., 1992. Neuropsychobiology, 25 (4) pp. 214-220.
[DOI][WoS][Pmid][serval:BIB_2B8ED0643D8D]
 
Light-induced racemization of the diastereoisomeric pairs of thioridazine 5-sulfoxide: origin of artifacts in the TDM of thioridazine
Eap Chin B., Souche Alain, Koeb Liliane, Baumann Pierre, 1992. pp. 111-115 dans Sunshine I. (eds.) Recent Developments in Therapeutic Drug Monitoring and Clinical Toxicology, Marcel Dekker, Inc..
[serval:BIB_8D7A67A8CC9A]
 
Plasma levels of trimipramine and metabolites in four patients: determination of the enantiomer concentrations of the hydroxy metabolites.
Eap C.B., Koeb L., Holsboer-Trachsler E., Baumann P., 1992. Therapeutic Drug Monitoring, 14 (5) pp. 380-385. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_131581FEE7CF]
 
Therapeutic drug monitoring: role of alpha1 - acid glycoprotein (AGP) binding
Baumann Pierre, Eap Chin B., 1992. pp. 153-157 dans Sunshine I. (eds.) Recent developments in therapeutic drug monitoring and clinical toxicology., Marcel Dekker.
[serval:BIB_570382D65408]
1991
 
Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice.
van Dijk W., Pos O., van der Stelt M.E., Moshage H.J., Yap S.H., Dente L., Baumann P., Eap C.B., 1991. Biochemical Journal, 276 ( Pt 2) pp. 343-347. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D91F15A791FA]
 
Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
Eap C.B., Souche A., Koeb L., Baumann P., 1991. Therapeutic Drug Monitoring, 13 (4) pp. 356-362. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B49CD6DFEF29]
 
Plasma monitoring of antidepressants: clinical relevance of the pharmacogenetic of metabolism and of a 1-acid glycoprotein binding
Baumann Pierre, Eap Chin B., 1991. pp. 362-364 dans Racagni G., Brunello N., Fukuda T. (eds.) Biological Psychiatry. Volume 1, Elsevier Science Publisher.
[serval:BIB_6A742D70791F]
 
Variations in relative concentrations of variants of human alpha 1-acid glycoprotein after acute-phase conditions.
Eap C.B., Fischer J.F., Baumann P., 1991. Clinica Chimica Acta; International Journal of Clinical Chemistry, 203 (2-3) pp. 379-385. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2FF907C524FE]
1990
 
Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein.
Eap C.B., Cuendet C., Baumann P., 1990. Clinical Pharmacology and Therapeutics, 47 (3) pp. 338-346. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_33D3B86707ED]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University